Oligonucleotides

Overview

Oligonucleotides are a nucleic-acid drug class whose commercial proof point was Spinraza. Spinraza marked the shift from promise to proof for antisense oligonucleotide therapies, showing they could sustain commercial manufacturing with the quality and regulatory confidence required for chronic treatment.